nderstanding anxiety and attendance in cervical screening
Not Applicable
Completed
- Conditions
- Cervical cancer screeningCancerMalignant neoplasm of cervix uteri
- Registration Number
- ISRCTN15113095
- Lead Sponsor
- niversity College London (UCL)
- Brief Summary
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34922447/ (added 20/12/2021) 2020 Other publications in https://doi.org/10.1002/pon.5540 Qualitative study (added 19/07/2023) 2021 Results article in https://doi.org/10.1093/abm/kaab022 (added 19/07/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 646
Inclusion Criteria
Women aged 24-65 who have tested positive for HPV with normal cytology within the last 2 weeks at NHSCSP HPV primary screening
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> For the observational component:<br> State anxiety and anxiety specific to cervical screening, measured using the State Trait Anxiety Inventory (S-STAI-6) and Cervical Screening Questionnaire (CSQ), respectively<br><br> For the interventional component:<br> Participation response rate<br><br> All outcomes measured at one timepoint only<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Illness beliefs measured using B-IPQ<br> 2. Symptom perception measured using adapted IPQ-R<br> 3. Coping style measured using adapted Brief COPE<br> 4. Concerns about HPV, disclosure of results, intention to re-attend screening, barriers to screening re-attendance, all measured using questions developed for the study<br> 5. Prospective 12-month screening attendance, measured using clinical records<br> 6. Demographics including: ethnicity, marital status, and highest level of education (all self-report)<br> 7. Age, index of multiple deprivation score, number of previous cervical screens, and NHS site, collected via clinical records<br> 8. Self-reported history of anxiety or depression<br><br> All outcomes with the exception of prospective 12-month cervical screening attendance measured at one timepoint only<br>